Renato Umeton

5.1k total citations · 2 hit papers
59 papers, 2.0k citations indexed

About

Renato Umeton is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Renato Umeton has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Renato Umeton's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Renato Umeton is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Renato Umeton collaborates with scholars based in United States, Italy and United Kingdom. Renato Umeton's co-authors include Charlotta Lindvall, Rosella Mechelli, Marco Salvetti, Giovanni Ristori, Maria Chiara Buscarinu, Silvia Romano, Viviana Annibali, Arianna Fornasiero, Claudia Policano and Vito A. G. Ricigliano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Renato Umeton

57 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Automated machine learning: Review of the state-of-the-art and opportunities for healthcare

2020 520 citations Renato Umeton et al. profile →
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis

2013 473 citations Rosella Mechelli, Renato Umeton et al. PLoS ONE profile →

Peers

Countries citing papers authored by Renato Umeton

Since Specialization

Citations

This map shows the geographic impact of Renato Umeton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Umeton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Umeton more than expected).

Fields of papers citing papers by Renato Umeton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Umeton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Umeton. The network helps show where Renato Umeton may publish in the future.

Co-authorship network of co-authors of Renato Umeton

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Umeton. A scholar is included among the top collaborators of Renato Umeton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Umeton. Renato Umeton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ChatGPT for digital pathology research 2024 ·The Lancet Digital Health ·Mohamed Omar, (unknown), Massimo Loda, Luigi Marchionni, Renato Umeton	14
2	Inferring gene regulatory networks of ALS from blood transcriptome profiles 2024 ·Heliyon ·Xena Giada Pappalardo, (unknown), (unknown), Jole Costanza, Renato Umeton, Francesca Guarino, Vito De Pinto, Stephen G. Oliver, Angela Messina, Giuseppe Nicosia	3
3	Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states 2023 ·Cell Reports Medicine ·Jackson Nyman, Thomas Denize, Ziad Bakouny, Chris Labaki, (unknown), Kevin Bi, (unknown), Jacob Rosenthal, (unknown), Bowen Jiang, Bijaya Sharma, Kristen D. Felt, Renato Umeton, David A. Braun, Scott J. Rodig, Toni K. Choueiri, Sabina Signoretti, Eliezer M. Van Allen	14
4	Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum 2020 ·Molecular Cancer Research ·Kathryn L. Penney, Svitlana Tyekucheva, Jacob Rosenthal, (unknown), (unknown), (unknown), Giorgia Zadra, Giuseppe Nicolò Fanelli, (unknown), Francesca Giunchi, Mark M. Pomerantz, (unknown), (unknown), Rosina T. Lis, Adam S. Kibel, Michelangelo Fiorentino, Renato Umeton, Massimo Loda	28
5	Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non–Small Cell Lung Cancer 2020 ·Clinical Cancer Research ·Biagio Ricciuti, Gonzalo Recondo, Liam F. Spurr, Yvonne Y. Li, Giuseppe Lamberti, Deepti Venkatraman, Renato Umeton, Andrew D. Cherniack, Mizuki Nishino, Lynette M. Sholl, Geoffrey I. Shapiro, Mark M. Awad, Michael L. Cheng	102
6	Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer 2020 ·Annals of Oncology ·Giuseppe Lamberti, Liam F. Spurr, Y. Li, Biagio Ricciuti, Gonzalo Recondo, Renato Umeton, Mizuki Nishino, Lynette M. Sholl, Matthew Meyerson, Andrew D. Cherniack, Mark M. Awad	66
7	MA09.11 Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer 2019 ·Journal of Thoracic Oncology ·Gonzalo Recondo, Magda Bahcall, Lynette M. Sholl, Giulia C. Leonardi, Biagio Ricciuti, Tom Nguyen, Deepti Venkatraman, Giuseppe Lamberti, Renato Umeton, Pasi A. Jänne, Mark M. Awad	4
8	P1.04-04 DNA Damage Response Gene Alterations Are Associated with High Tumor Mutational Burden and Clinical Benefit from PD-1 Axis Inhibition in NSCLC 2019 ·Journal of Thoracic Oncology ·Biagio Ricciuti, (unknown), Gonzalo Recondo, Renato Umeton, Mizuki Nishino, Lynette M. Sholl, Mark M. Awad	0
9	OA03.07 Immune-Related Adverse Events and Clinical Outcome to Anti PD-1 Axis Inhibition in SCLC: A Multicenter Retrospective Analysis 2019 ·Journal of Thoracic Oncology ·Biagio Ricciuti, Abdul Rafeh Naqash, Brian S. Henick, Deepa Rangachari, Jarushka Naidoo, Deepti Venkatraman, Giuseppe Lamberti, Gonzalo Recondo, (unknown), (unknown), (unknown), Paul R. Walker, Kartik Sehgal, Renato Umeton, Lynette M. Sholl, Naiyer A. Rizvi, Daniel B. Costa, Mark M. Awad	3
10	Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer 2019 ·Journal for ImmunoTherapy of Cancer ·Biagio Ricciuti, Sasha Kravets, Suzanne E. Dahlberg, Renato Umeton, Adem Albayrak, (unknown), Bruce E. Johnson, Mizuki Nishino, Lynette M. Sholl, Mark M. Awad	64
11	P2.04-32 Comparison of Clinicopathological and Genomic Characteristics Between NSCLCs with a PD-L1 Tumor Proportion Score of ≥90% vs <1% 2019 ·Journal of Thoracic Oncology ·Giuseppe Lamberti, Y. Li, Liam F. Spurr, Biagio Ricciuti, Gonzalo Recondo, Renato Umeton, Lynette M. Sholl, (unknown), Mark M. Awad	2
12	TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) 2019 ·Romualdo Barroso‐Sousa, Svitlana Tyekucheva, Pedro Exman, Renato Umeton, F. Stephen Hodi, Eric P. Winer, Nancy U. Lin, Sara M. Tolaney	1
13	Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites 2018 ·Clinical Cancer Research ·Amin H. Nassar, Renato Umeton, Jaegil Kim, (unknown), Lauren C. Harshman, Eliezer M. Van Allen, Mark A. Preston, Fei Dong, Joaquim Bellmunt, Kent W. Mouw, Toni K. Choueiri, Guru Sonpavde, David J. Kwiatkowski	87
14	Mismatch Repair Deficiency in High-Grade Meningioma: A Rare but Recurrent Event Associated With Dramatic Immune Activation and Clinical Response to PD-1 Blockade 2018 ·JCO Precision Oncology ·Ian F. Dunn, Ziming Du, Mehdi Touat, Michael B. Sisti, Patrick Y. Wen, Renato Umeton, Adrian M. Dubuc, Matthew D. Ducar, Peter Canoll, Eric A. Severson, Julia A. Elvin, Shakti Ramkissoon, Jia‐Ren Lin, (unknown), (unknown), Peter K. Sorger, Keith L. Ligon, Sandro Santagata, David A. Reardon	51
15	MA19.01 Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes 2018 ·Journal of Thoracic Oncology ·Natalie I. Vokes, (unknown), Anika E. Adeni, Renato Umeton, Lynette M. Sholl, Hira Rizvi, Matthew D. Hellmann, Mark M. Awad, Eli Van Allen	9
16	A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis breakdown → 2013 ·PLoS ONE ·Rosella Mechelli, Renato Umeton, Claudia Policano, Viviana Annibali, Giulia Coarelli, Vito A. G. Ricigliano, (unknown), Arianna Fornasiero, Maria Chiara Buscarinu, Silvia Romano, Marco Salvetti, Giovanni Ristori	473
17	Contribution of Genome-Wide Association Studies to Scientific Research: A Pragmatic Approach to Evaluate Their Impact 2013 ·PLoS ONE ·Vito A. G. Ricigliano, Renato Umeton, (unknown), (unknown), Martina Briani, (unknown), (unknown), Giorgia Pierelli, (unknown), (unknown), Francesca Grassi, Gabriella Palmieri, Marco Salvetti	5
18	OREMPdb: a semantic dictionary of computational pathway models 2012 ·BMC Bioinformatics ·Renato Umeton, Giuseppe Nicosia, C. Forbes Dewey	4
19	OREMP: Ontology Reasoning Engine for Molecular Pathways 2010 ·Bioscience Reports ·Renato Umeton, Beracah Yankama, Giuseppe Nicosia, C. Forbes Dewey	1
20	Highway traffic model based on cellular automata: preliminary simulation results with congestion pricing considerations 2008 ·Annual Simulation Symposium ·Salvatore Di Gregorio, Renato Umeton, (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact